Published in Gut on June 01, 1979
Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut (1980) 4.24
The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab (2011) 3.54
Short chain fatty acids in the human colon. Gut (1981) 3.49
Composition of human colonic mucin. Selective alteration in inflammatory bowel disease. J Clin Invest (1983) 2.03
Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut (2000) 1.75
Fuel utilization in colonocytes of the rat. Biochem J (1985) 1.42
Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br J Exp Pathol (1986) 1.35
Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut (1995) 1.26
Keratins modulate colonocyte electrolyte transport via protein mistargeting. J Cell Biol (2004) 1.18
Impaired sulphation of phenol by the colonic mucosa in quiescent and active ulcerative colitis. Gut (1991) 1.11
Microbial regulation of glucose metabolism and cell-cycle progression in mammalian colonocytes. PLoS One (2012) 1.05
Stimulation of sodium chloride absorption from secreting rat colon by short-chain fatty acids. Dig Dis Sci (1999) 0.98
Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice. Clin Cancer Res (2014) 0.94
Oxidation of short and medium chain C2-C8 fatty acids in Sprague-Dawley rat colonocytes. Gut (1997) 0.92
Colonic epithelial metabolism in ulcerative colitis. Gut (1993) 0.90
Comparison of 5-aminosalicylic acid and N-acetylaminosalicylic acid uptake by the isolated human colonic epithelial cell. Gut (1992) 0.84
Experimental inflammation of the rat distal colon inhibits ion secretion in the proximal colon by affecting the enteric nervous system. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.83
Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis. Dig Dis Sci (2001) 0.83
Effect of sulphide on short chain acyl-CoA metabolism in rat colonocytes. Gut (1997) 0.81
Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis? Gut (1995) 0.79
Obesity, rather than diet, drives epigenomic alterations in colonic epithelium resembling cancer progression. Cell Metab (2014) 0.79
Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro. Postgrad Med J (2005) 0.78
Thiol methyltransferase activity in colonocytes and erythrocyte membranes. J Clin Pathol (1995) 0.78
Cytophotometric and flow cytometric DNA content of isolated glands in gastric neoplasia. Gut (1995) 0.77
5-aminosalicylic acid (5-ASA) can reduce levels of oxidative DNA damage in cells of colonic mucosa with and without fecal stream. Dig Dis Sci (2010) 0.77
Regulation of mucus secretion by cells isolated from the rat gastric mucosa. J Physiol (1990) 0.77
Use of buffered formaldehyde in the enzymatic digestion of inflamed mucosa. J Clin Pathol (1996) 0.75
Influence of feces from patients with ulcerative colitis on butyrate oxidation in rat colonocytes. Dig Dis Sci (1999) 0.75
Preparation and properties of mucosl epithelial cells isolated frmsmall intestine of the chicken. Biochemistry (1970) 2.09
Ketogenesis from butyrate and acetate by the caecum and the colon of rabbits. Biochem J (1972) 1.73
ABSORPTION OF SHORT CHAIN FATTY ACIDS IN MAN. Proc Soc Exp Biol Med (1964) 1.58
A simple method for the isolation of viable epithelial cells of the gastrointestinal (GI) tract. Proc Soc Exp Biol Med (1973) 1.19
Simple method for the preparation of single cell suspensions from normal and tumorous rat colonic mucosa. Gut (1977) 1.16
Isolation of intestinal mucosa cells. Methods Enzymol (1974) 1.15
An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet (1977) 7.89
A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut (1973) 6.09
The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol (1972) 6.07
Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J (1970) 4.31
Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut (1980) 4.24
Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet (1974) 4.06
Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology (1982) 3.92
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. Br Med J (1979) 3.56
Transit times of food in patients with diverticulosis or irritable colon syndrome and normal subjects. Br Med J (1967) 3.51
Prevalence of colonic diverticulosis in general population of Oxford area. Br Med J (1967) 3.44
The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet (1980) 3.32
Course and prognosis of Crohn's disease. Gut (1976) 3.02
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut (1980) 2.81
Gastric ulcer and gastritis. Gut (1971) 2.58
Gastric cancer simulating benign gastric ulcer. Br J Surg (1969) 2.27
Auto-immune reactions in ulcerative colitis. Gut (1966) 2.26
Further experience in the treatment of severe attacks of ulcerative colitis. Lancet (1978) 2.25
Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J (1974) 2.24
Jejunal mucosal recovery in coeliac disease in relation to the degree of adherence to a gluten-free diet. Q J Med (1974) 1.95
Ulcerative colitis and pregnancy. Gut (1980) 1.90
The histological classification of duodenitis in fibreoptic biopsy specimens. Digestion (1975) 1.89
Crohn's disease and carcinoma of colon. Br Med J (1968) 1.77
Abnormalities in the apparently normal bowel mucosa in Crohn's disease. Lancet (1976) 1.77
Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis. Gut (1982) 1.60
Gastroscopy with biopsy and cytological sampling under direct vision. Br Med J (1968) 1.53
Disaccharidase activity and jejunal morphology in coeliac disease. Q J Med (1972) 1.48
The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis. Scand J Gastroenterol (1980) 1.46
Hypolactasia and the irritable colon syndrome. Scand J Gastroenterol (1972) 1.42
The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol (1982) 1.40
Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis. Lancet (1979) 1.40
Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine. Clin Exp Immunol (1974) 1.39
Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br J Exp Pathol (1986) 1.35
Circulating and tissue eosinophils in ulcerative colitis. Am J Dig Dis (1966) 1.32
Lack of harmful effect of oats on small-intestinal mucosa in coeliac disease. Br Med J (1974) 1.31
Stimulation of lymphocytes from patients with coeliac disease by a subfraction of gluten. Lancet (1976) 1.31
Propulsion and retropulsion of normal colonic contents. Am J Dig Dis (1971) 1.30
The timing of histological damage following a single challenge with gluten in treated coeliac disease. Q J Med (1981) 1.29
Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial. Br Med J (1972) 1.28
The liver in ulcerative colitis. Q J Med (1971) 1.27
Glucosamine synthetase activity of the colonic mucosa in ulcerative colitis and Crohn's disease. Gut (1977) 1.26
Gastritis duodenitis, and circulating levels of gastrin in duodenal ulcer before and after vagotomy. Gut (1976) 1.25
Cerebral venous thrombosis as a complication of ulcerative colitis. Am J Dig Dis (1967) 1.25
Comparison of various treatments for irritable bowel syndrome. Br Med J (1980) 1.20
The role of various cereals in coeliac disease. Q J Med (1978) 1.19
The liver in Crohn's disease. Q J Med (1971) 1.16
Circulating antibodies to cow's milk proteins in ulcerative colitis. Gut (1972) 1.16
Identifying toxic fractions of wheat gluten and their effect on the jejunal mucosa in coeliac disease. Gut (1974) 1.13
Proctocolectomy for ulcerative colitis. World J Surg (1980) 1.12
Campylobacter colitis. J Clin Pathol (1979) 1.12
Impaired sulphation of phenol by the colonic mucosa in quiescent and active ulcerative colitis. Gut (1991) 1.11
Intensive intravenous regimen for membranous colitis. Br Med J (1976) 1.11
Tissue eosinophils in ulcerative colitis. Scand J Gastroenterol (1979) 1.10
The management of ulcerative colitis. Br J Clin Pract (1974) 1.07
Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey. Gut (1983) 1.06
Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis. Gut (1980) 1.06
Luminal ions and short chain fatty acids as markers of functional activity of the mucosa in ulcerative colitis. J Clin Pathol (1982) 1.05
Water and electrolyte balance in subjects with a permanent ileostomy. Gut (1983) 1.05
Placental and mammary transfer of sulphasalazine. Br Med J (1979) 1.04
The effects of prednisolone in leucocyte function in man. A double blind controlled study. Clin Exp Immunol (1977) 1.04
Movements of the large intestine. Physiol Rev (1966) 1.04
Skin test for coeliac disease using a subfraction of gluten. Lancet (1977) 1.04
The health of subjects living with a permanent ileostomy. Q J Med (1982) 1.04
Segmentation and the localization of intraluminal pressure in the human colon, with special reference to the pathogenesis of colonic diverticula. Gastroenterology (1968) 1.01
Metabolic basis of starvation diarrhoea: implications for treatment. Lancet (1986) 1.01
Effect of short-chaim fatty acid on sodium absorption in isolated human colon perfused through the vascular bed. Dig Dis Sci (1981) 1.00
Breakfast and Crohn's disease--I. Br Med J (1978) 1.00
Colonic bicarbonate output as a test of disease activity in ulcerative colitis. J Clin Pathol (1984) 0.99
Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis. Clin Exp Immunol (1976) 0.96
Trophic effect of short chain fatty acids on mucosal handling of ions by the defunctioned colon. Br J Surg (1982) 0.95
Detectable colonic nitrite levels in inflammatory bowel disease--mucosal or bacterial malfunction? Digestion (1986) 0.95
The effect of the acetylator phenotype on the metabolism of sulphasalazine in man. J Med Genet (1983) 0.94
Circulating immune complexes in ulcerative colitis and Crohn's disease. Gut (1972) 0.94
Decreased sulphur aminoacid intake in ulcerative colitis. Lancet (1998) 0.94
Stump appendicitis--a potential problem after laparoscopic appendicectomy. Surg Laparosc Endosc (1997) 0.92
Pericarditis associated with ulcerative colitis and Crohn's disease. Am J Dig Dis (1976) 0.92
Localization of the nonpalpable colonic lesion with intraoperative ultrasound. Surg Endosc (1999) 0.92
Estimation of phenolic conjugation by colonic mucosa. J Clin Pathol (1989) 0.91
Medical management of ulcerative colitis. Br Med J (1968) 0.91
Haustral movement in the human colon. Gut (1969) 0.90
Reaginic hypersensitivity in ulcerative colitis. Gut (1972) 0.90
Colonic epithelial metabolism in ulcerative colitis. Gut (1993) 0.90
Blood Groups and Secretor Status in Ulcerative Colitis. Br Med J (1961) 0.89
Congenital thyroid cyst of ultimobranchial gland origin. J Pediatr Surg (1977) 0.88
Endocrine and cytokine changes during elective surgery. J Clin Pathol (1994) 0.88
Disodium azodisalicylate in ulcerative colitis. Lancet (1981) 0.87
The thyroid in ulverative colitis and Crohn's disease. II. Thyroid enlargement and hyperthyroidism in ulcerative colitis. Acta Med Scand (1975) 0.87
Hydrogen sulphide produces diminished fatty acid oxidation in the rat colon in vivo: implications for ulcerative colitis. Aust N Z J Surg (1997) 0.84
The effects of enterotoxins and short-chain fatty acids on water and electrolyte fluxes in ileal and colonic loops in vivo in the rat. Digestion (1990) 0.84
Human colonic motility. A comparative study of normal subjects, patients with ulcerative colitis, and patients with the irritable colon syndrome. Gastroenterology (1968) 0.83
Hookworm infection in Great Britain: experimental observations. Br Med J (1965) 0.83
Mucous extravasation theory as a cause of plunging ranulas. Br J Surg (1973) 0.83
Propulsion and retropulsion in the human colon demonstrated by time-lapse cinefluorography. Gut (1968) 0.83
Gut hormone responses in subjects with a permanent ileostomy. Digestion (1982) 0.82
Bacterial short chain fatty acids: their role in gastrointestinal disease. Dig Dis (1990) 0.82
Observations on experimentally induced colonic pain. Gut (1972) 0.82
Pathogenesis and treatment of plunging ranulas. Surg Gynecol Obstet (1977) 0.82
Morphology and disaccharidase levels of jejunal biopsy specimens from healt by british subjects. Digestion (1973) 0.81